摘要:
The pharmaceutical use of novel compounds of formula I: where
Z is a structure of formula
A-B is -C=CH- or -C(R 5 )-CH 2 -; X is S or NR 4 ; R 1 is H, halo, formyl, C 1 -C 4 alkyl, C 1 -C 4 alkoxy, thienylmethyloxy, 4,5-dihydrothiazol-2-yl, cyano, nitro, carboxamido, trifluoromethyl or hydroxy; R 2 is H or halo; R 3 is H, C 1 -C 4 alkyl, (C 1 -C 4 alkylene)-aryl, or -CH 2 -Y-NR 7 R 8 ; R 4 is H, C 1 -C 4 alkyl, C 1 -C 5 acyl, or phenylsulfonyl; R 5 is H or OH; R 6 is H or methyl; Y is -CH 2 - or -C(O)-; R 7 is pyridinyl; and R 8 is H or -C(O)-(C 3 -C 6 cycloalkyl); and pharmaceutically acceptable salts thereof.
摘要翻译:其中Z是式CHEM A-B的结构的式I的新化合物:其中Z是-C = CH-或-C(R 5)-CH 2 - ; X是S或NR 4; R 1是H,卤素,甲酰基,C 1 -C 4烷基,C 1 -C 4烷氧基,噻吩基甲氧基,4,5-二氢噻唑-2-基,氰基,硝基,甲酰胺基,三氟甲基或羟基; R 2是H或卤素; R 3是H,C 1 -C 4烷基,(C 1 -C 4亚烷基) - 芳基或-CH 2 -Y-NR 7 R 8; R 4是H,C 1 -C 4烷基,C 1 -C 5酰基或苯基磺酰基; R 5是H或OH; R 6是H或甲基; Y是-CH 2 - 或-C(O) - ; R 7是吡啶基; 和R 8是H或-C(O) - (C 3 -C 6环烷基); 及其药学上可接受的盐。
摘要:
A process for preparing 10b-methyl-3-oxo-benzo[f] quinolines of the formula
wherein R is hydrogen, methylthio, chloro, bromo or fluoro, and is located at the 7-, 8- or 9-position; comprising reacting a compound of the formula
with methyl iodide in an ether solvent to prepare a compound of the formula
combining acrylic anhydride or acryloyl chloride with the reaction mixture comprising the compound of formula III to prepare a compound of the formula
quenching the reaction with sodium bicarbonate, evaporating the organic solution comprising the compound of formula IV; and combining the residue comprising the compound of formula IV with a trialkylsilane and trifluoroacetic acid in the absence of a solvent to prepare the compound of formula I.
摘要:
The pharmaceutical use of novel compounds of formula I: where Z is a structure of formula
A-B is -C=CH- or -C(R 5 )-CH 2 -; X is S or NR 4 ; R 1 is H, halo, formyl, C 1 -C 4 alkyl, C 1 -C 4 alkoxy, thienylmethyloxy, 4,5-dihydrothiazol-2-yl, cyano, nitro, carboxamido, trifluoromethyl or hydroxy;
R 2 is H or halo; R 3 is H, C 1 -C 4 alkyl, (C 1 -C 4 alkylene)-aryl, or -CH 2 -Y-NR 7 R 8 ; R 4 is H, C 1 -C 4 alkyl, C 1 -C 5 acyl, or phenylsulfonyl; R 5 is H or OH; R 6 is H or methyl; Y is -CH 2 - or -C(O)-; R 7 is pyridinyl; and R 8 is H or -C(O)-(C 3 -C 6 cycloalkyl); and pharmaceutically acceptable salts thereof.
摘要:
A series of benzoquinolin-3-ones as defined in Claim 1, are pharmaceuticals effective in preventing the development of prostatic cancer, or preventing or treating the metastasis to bone of prostatic cancer.
摘要:
This invention relates to hexa- and octahydrobenzo[f]quinolin-3-ones, pharmaceutical formulations containing those compounds and methods of their use as steroid 5α reductase inhibitors.
摘要:
The present invention provides methods of inhibiting bone loss in mammals via the administration to a mammal in need of such treatment an effective amount of a compound from a series of benzoquinolin-3-ones. Such compounds also are sequentially or concurrently coadministered with a bone antiresorptive agent or a bone anabolic agent.
摘要:
The present invention provides methods of inhibiting bone loss in mammals via the administration to a mammal in need of such treatment an effective amount of a compound from a series of benzoquinolin-3-ones. Such compounds also are sequentially or concurrently coadministered with a bone antiresorptive agent or a bone anabolic agent.
摘要:
The present invention provides novel tetrahydrobeta-carboline compounds and intermediates having useful central nervous system activity. The invention provides formulations and methods for using the novel tetrahydrobeta-carboline compounds. Further provided, is a new Pictet-Spengler process useful for preparing tetrahydrobeta-carboline compounds.
摘要:
The present invention provides novel tetrahydro-beta-carboline compounds having useful central nervous system activity. Further, there is provided 3-ethanamine and 3-ethanamine related compounds which are useful intermediates and have beneficial central nervous system activity. The invention provides formulations and methods for using the novel tetrahydro-beta-carboline and related compounds.